KR950701812A - 렌티바이러스-유도된 질환의 치료에 유용한 생물학적으로 활성인 우레이도 유도체(Biologically active ureido dervatives useful in the treatment of lentivirus-induced sisease) - Google Patents

렌티바이러스-유도된 질환의 치료에 유용한 생물학적으로 활성인 우레이도 유도체(Biologically active ureido dervatives useful in the treatment of lentivirus-induced sisease)

Info

Publication number: KR950701812A
Authority: KR; South Korea
Prior art keywords: sisease; dervatives; lentivirus; induced; useful
Prior art date: 1993-04-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

KR1019940704567A

Other languages

English (en)

Korean (ko)

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-04-16

Filing date

1994-12-15

Publication date

1995-05-17

1994-12-15 Application filed filed Critical

1995-05-17 Publication of KR950701812A publication Critical patent/KR950701812A/ko

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrrole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

KR1019940704567A 1993-04-16 1994-12-15 렌티바이러스-유도된 질환의 치료에 유용한 생물학적으로 활성인 우레이도 유도체(Biologically active ureido dervatives useful in the treatment of lentivirus-induced sisease) Ceased KR950701812A (ko)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB939307948A GB9307948D0 (en)	1993-04-16	1993-04-16	Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
PCT/EP1994/000984 WO1994023718A1 (en)	1993-04-16	1994-03-29	Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease

Publications (1)

Publication Number	Publication Date
KR950701812A true KR950701812A (ko)	1995-05-17

Family

ID=10733998

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
KR1019940704567A Ceased KR950701812A (ko)	1993-04-16	1994-12-15	렌티바이러스-유도된 질환의 치료에 유용한 생물학적으로 활성인 우레이도 유도체(Biologically active ureido dervatives useful in the treatment of lentivirus-induced sisease)

Country Status (15)

Country	Link
EP (1)	EP0646004A1 (ru)
JP (1)	JPH07508044A (ru)
KR (1)	KR950701812A (ru)
AU (1)	AU670194B2 (ru)
CA (1)	CA2137148A1 (ru)
CZ (1)	CZ282988B6 (ru)
GB (1)	GB9307948D0 (ru)
HU (1)	HU216834B (ru)
IL (1)	IL109235A (ru)
NO (1)	NO307126B1 (ru)
PL (1)	PL306798A1 (ru)
RU (1)	RU2142798C1 (ru)
TW (1)	TW308593B (ru)
UA (1)	UA42693C2 (ru)
WO (1)	WO1994023718A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9504065D0 (en) *	1995-03-01	1995-04-19	Pharmacia Spa	Poly-pyrrolecarboxamidonaphthalenic acid derivatives
GB9602721D0 (en) *	1996-02-09	1996-04-10	Pharmacia Spa	Biologically active ureido derivatives useful in the treatment of multiple sclerosis
GB2310207A (en) *	1996-02-15	1997-08-20	Pharmacia Spa	Antiviral ureido derivatives of substituted heterocyclic compounds
GB9713733D0 (en) *	1997-06-27	1997-09-03	Pharmacia & Upjohn Spa	Poly-branched polycarboxamido compounds
EP3381897A1 (en)	2017-03-27	2018-10-03	Leadiant Biosciences SA	Derivatives of the disodium 2,2'-{carbonylbis[imino-3,1-phenylenecarbonylimino(1-methyl-1h-pyrrole-4,2-diyl)carbonylimino]}dinaphthalene-1,5-disulfonate salt and related compounds as heparanase inhibitors for the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9000644D0 (en) *	1990-01-11	1990-03-14	Erba Carlo Spa	New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds
AU1224392A (en) *	1991-02-06	1992-09-07	Synphar Laboratories, Inc.	Oligopeptide antiretroviral agents
IT1247878B (it) *	1991-02-15	1995-01-05	Menarini Farma Ind	Derivati poli-4-aminopirrol-2-carbossiamidici,processi di preparazione e composizioni farmaceutiche che li contengono

1993
- 1993-04-16 GB GB939307948A patent/GB9307948D0/en active Pending
1994
- 1994-03-29 PL PL94306798A patent/PL306798A1/xx unknown
- 1994-03-29 CA CA002137148A patent/CA2137148A1/en not_active Abandoned
- 1994-03-29 RU RU94046312A patent/RU2142798C1/ru active
- 1994-03-29 CZ CZ95107A patent/CZ282988B6/cs unknown
- 1994-03-29 AU AU65371/94A patent/AU670194B2/en not_active Ceased
- 1994-03-29 JP JP6522676A patent/JPH07508044A/ja active Pending
- 1994-03-29 WO PCT/EP1994/000984 patent/WO1994023718A1/en not_active Ceased
- 1994-03-29 UA UA94129236A patent/UA42693C2/ru unknown
- 1994-03-29 HU HU9500120A patent/HU216834B/hu not_active IP Right Cessation
- 1994-03-29 EP EP94913075A patent/EP0646004A1/en not_active Withdrawn
- 1994-04-06 IL IL10923594A patent/IL109235A/en not_active IP Right Cessation
- 1994-04-12 TW TW083103216A patent/TW308593B/zh active
- 1994-12-12 NO NO944809A patent/NO307126B1/no not_active IP Right Cessation
- 1994-12-15 KR KR1019940704567A patent/KR950701812A/ko not_active Ceased

Also Published As

Publication number	Publication date
AU6537194A (en)	1994-11-08
NO307126B1 (no)	2000-02-14
JPH07508044A (ja)	1995-09-07
NO944809L (no)	1994-12-12
HU216834B (hu)	1999-09-28
RU2142798C1 (ru)	1999-12-20
CZ10795A3 (en)	1995-09-13
CZ282988B6 (cs)	1997-12-17
RU94046312A (ru)	1996-10-20
PL306798A1 (en)	1995-04-18
HUT71838A (en)	1996-02-28
EP0646004A1 (en)	1995-04-05
CA2137148A1 (en)	1994-10-27
HU9500120D0 (en)	1995-03-28
WO1994023718A1 (en)	1994-10-27
IL109235A (en)	1998-09-24
TW308593B (ru)	1997-06-21
GB9307948D0 (en)	1993-06-02
IL109235A0 (en)	1994-07-31
UA42693C2 (ru)	2001-11-15
NO944809D0 (no)	1994-12-12
AU670194B2 (en)	1996-07-04

Publication	Publication Date	Title
FI955315L (fi)	1995-11-06	HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n hoitoon
MX9101035A (es)	1992-05-04	Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene
FI955129A7 (fi)	1995-10-27	Viljelyksessä käytettävät aktiivisten aineiden konsentroidut koostumuk set
FI956050L (fi)	1995-12-15	Biologisesti aktiiviset vasopressiinianalogit
KR950701812A (ko)	1995-05-17	렌티바이러스-유도된 질환의 치료에 유용한 생물학적으로 활성인 우레이도 유도체(Biologically active ureido dervatives useful in the treatment of lentivirus-induced sisease)
GB9304589D0 (en)	1993-04-21	Biologically active ureido derivatives useful as antimetastic agents
IL95561A0 (en)	1991-06-30	Method for the purification and concentration of biologically active materials
GB2280604B (en)	1997-04-30	Processing of active agents
FR2733418B1 (fr)	1997-08-01	Nouvelles associations comprenant du (-) hydroxycitrate et presentant notamment de nouvelles activites therapeutiques
BR9702075A (pt)	1998-06-09	Derivados de uréida biologicamente ativos úteis no tratamento de esclerose múltipla
NO960308D0 (no)	1996-01-25	Terapeutisk aktive benzoksaziner og benzotioanoner
GB9308573D0 (en)	1993-06-09	Biologically and therapeutically active agents
GB9309565D0 (en)	1993-06-23	Biologically and therapeutically active agents
GB9306974D0 (en)	1993-05-26	Biologically and therapeutically active agents against hiv-1
GB9310608D0 (en)	1993-07-07	Biologically active dermatological treatment
DK69793D0 (da)	1993-06-14	In vivo aktive forbindelser
GB9017812D0 (en)	1990-09-26	Biologically and therapeutically active agents against hiv-1
GB9207273D0 (en)	1992-05-13	Biologically and therapeutically active agents
GB9215546D0 (en)	1992-09-02	Biologically and therapeutically active agents
ITMI920994A1 (it)	1993-10-28	Modulo prefabbricato in particolare per l'esecuzione di rivestimenti arginali e ferma-telo.
GB9119202D0 (en)	1991-10-23	Biologically and therapeutically active agents
GB9108962D0 (en)	1991-06-12	Biologically and therapeutically active agents against hiv-1
GB9125436D0 (en)	1992-01-29	Biologically and therapeutically active agents against hiv-1
GB9218772D0 (en)	1992-10-21	Biologically active dermatological treatment
GB9205784D0 (en)	1992-04-29	Biologically and therapeutically active agents against hiv-1

Legal Events

Date	Code	Title	Description
1994-12-15	PA0105	International application	Patent event date: 19941215 Patent event code: PA01051R01D Comment text: International Patent Application
1995-05-17	PG1501	Laying open of application
1996-12-28	N231	Notification of change of applicant
1996-12-28	PN2301	Change of applicant	Patent event date: 19961228 Comment text: Notification of Change of Applicant Patent event code: PN23011R01D
1999-03-26	A201	Request for examination
1999-03-26	AMND	Amendment
1999-03-26	PA0201	Request for examination	Patent event code: PA02012R01D Patent event date: 19990326 Comment text: Request for Examination of Application
2000-10-31	E902	Notification of reason for refusal
2000-10-31	PE0902	Notice of grounds for rejection	Comment text: Notification of reason for refusal Patent event date: 20001031 Patent event code: PE09021S01D
2001-01-31	AMND	Amendment
2001-07-26	E601	Decision to refuse application
2001-07-26	PE0601	Decision on rejection of patent	Patent event date: 20010726 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20001031 Comment text: Notification of reason for refusal Patent event code: PE06011S01I
2001-08-29	J201	Request for trial against refusal decision
2001-08-29	PJ0201	Trial against decision of rejection	Patent event date: 20010829 Comment text: Request for Trial against Decision on Refusal Patent event code: PJ02012R01D Patent event date: 20010726 Comment text: Decision to Refuse Application Patent event code: PJ02011S01I Appeal kind category: Appeal against decision to decline refusal Decision date: 20021226 Appeal identifier: 2001101002891 Request date: 20010829
2001-09-27	AMND	Amendment
2001-11-12	PB0901	Examination by re-examination before a trial	Comment text: Amendment to Specification, etc. Patent event date: 20010927 Patent event code: PB09011R02I Comment text: Request for Trial against Decision on Refusal Patent event date: 20010829 Patent event code: PB09011R01I Comment text: Amendment to Specification, etc. Patent event date: 20010131 Patent event code: PB09011R02I Comment text: Amendment to Specification, etc. Patent event date: 19990326 Patent event code: PB09011R02I
2002-01-30	B601	Maintenance of original decision after re-examination before a trial
2002-01-30	PB0601	Maintenance of original decision after re-examination before a trial
2002-12-26	J301	Trial decision	Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20010829 Effective date: 20021226 Free format text: TRIAL NUMBER: 2001101002891; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20010829 Effective date: 20021226
2002-12-26	PJ1301	Trial decision	Patent event code: PJ13011S01D Patent event date: 20021226 Comment text: Trial Decision on Objection to Decision on Refusal Appeal kind category: Appeal against decision to decline refusal Request date: 20010829 Decision date: 20021226 Appeal identifier: 2001101002891